Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3270-3280

  Bu, So Young ^a   Mashek, Douglas G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID TRANSPORTER; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 5; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL ESTERIFICATION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME SYNTHESIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; COENZYME A LIGASES; ESTERIFICATION; FATTY ACIDS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTES; LIPOGENESIS; LIVER; MALE; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 78149314978     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M009407     Document Type: Article

References (42)

1. Mashek, D. G., and R. A. Coleman. 2006. Cellular fatty acid uptake: the contribution of metabolism. Curr. Opin. Lipidol. 17: 274-278.
2. Mashek, D. G., L. O. Li, and R. A. Coleman. 2007. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol. 2: 465-476.
3. Mashek, D. G., L. O. Li, and R. A. Coleman. 2006. Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47: 2004-2010.
4. Watkins, P. A. 2008. Very-long-chain acyl-CoA synthetases. J. Biol. Chem. 283: 1773-1777.
5. Li, L. O., D. G. Mashek, J. An, S. D. Doughman, C. B. Newgard, and R. A. Coleman. 2006. Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J. Biol. Chem. 281: 37246-37255.
6. Yao, H., and J. Ye. 2008. Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. 283: 849-854.
7. Bu, S. Y., M. T. Mashek, and D. G. Mashek. 2009. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 284: 30474-30483.
8. Mashek, D. G., M. A. McKenzie, C. G. Van Horn, and R. A. Coleman. 2006. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells. J. Biol. Chem. 281: 945-950.
9. Lewin, T. M., C. G. Van Horn, S. K. Krisans, and R. A. Coleman. 2002. Rat liver acyl-CoA synthetase 4 is a peripheral-membrane protein located in two distinct subcellular organelles, peroxisomes, and mitochondrial-associated membrane. Arch. Biochem. Biophys. 404: 263-270.
10. Oikawa, E., H. Iijima, T. Suzuki, H. Sasano, H. Sato, A. Kamataki, H. Nagura, M. J. Kang, T. Fujino, H. Suzuki, et al. 1998. A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes. J. Biochem. 124: 679-685. (Pubitemid 28456894)
11. Yu, X. X., D. A. Lewin, W. Forrest, and S. H. Adams. 2002. Cold elicits the simultaneous induction of fatty acid synthesis and beta-oxidation in murine brown adipose tissue: prediction from differential gene expression and confirmation in vivo. FASEB J. 16: 155-168.
12. Achouri, Y., B. D. Hegarty, D. Allanic, D. Becard, I. Hainault, P. Ferre, and F. Foufelle. 2005. Long chain fatty acyl-CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie. 87: 1149-1155. (Pubitemid 41572644)
13. Liang, C. P., and A. R. Tall. 2001. Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J. Biol. Chem. 276: 49066-49076.
14. Horton, J. D., N. A. Shah, J. A. Warrington, N. N. Anderson, S. W. Park, M. S. Brown, and J. L. Goldstein. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA. 100: 12027-12032.
15. Stoeckman, A. K., and H. C. Towle. 2002. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J. Biol. Chem. 277: 27029-27035.
16. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
17. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
18. Lewin, T. M., S. L. Wang, C. A. Nagle, C. G. Van Horn, and R. A. Coleman. 2005. Mitochondrial glycerol-3-phosphate acyltransferase- 1 directs the metabolic fate of exogenous fatty acids in hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288: E835-E844.
19. Chakravarthy, M. V., Z. J. Pan, Y. M. Zhu, K. Tordjman, J. G. Schneider, T. Coleman, J. Turk, and C. F. Semenkovich. 2005. "New" hepatic fat activates PPAR alpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1: 309-322.
20. Pawar, A., and D. B. Jump. 2003. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatoctes. J. Biol. Chem. 278: 35931-35939.
21. Sapiro, J. M., M. T. Mashek, A. S. Greenberg, and D. G. Mashek. 2009. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity. J. Lipid Res. 50: 1621-1629.
22. Lewin, T. M., H. de Jong, N. J. M. Schwerbrock, L. E. Hammond, S. M. Watkins, T. P. Combs, and R. A. Coleman. 2008. Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition. Biochim. Biophys. Acta. Mol. Cell Biol. Lipids. 1781: 352-358.
23. Stone, S. J., M. C. Levin, P. Zhou, J. Y. Han, T. C. Walther, and R. V. Farese. 2009. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 284: 5352-5361.
24. Kim, J. H., T. M. Lewin, and R. A. Coleman. 2001. Expression and characterization of recombinant rat acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J. Biol. Chem. 276: 24667-24673.
25. Lewin, T. M., J. H. Kim, D. A. Granger, J. E. Vance, and R. A. Coleman. 2001. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276: 24674-24679.
26. Linden, D., L. William-Olsson, M. Rhedin, A. K. Asztely, J. C. Clapham, and S. Schreyer. 2004. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J. Lipid Res. 45: 1279-1288. (Pubitemid 38802631)
27. Hammond, L. E., S. Neschen, A. J. Romanelli, G. W. Cline, O. R. Ilkayeva, G. I. Shulman, D. M. Muoio, and R. A. Coleman. 2005. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J. Biol. Chem. 280: 25629-25636.
28. Finck, B. N., M. C. Gropler, Z. J. Chen, T. C. Leone, M. A. Croce, T. E. Harris, J. C. Lawrence, and D. P. Kelly. 2006. Lipin 1 is an inducible amplifier of the hepatic PGC-1 alpha/PPAR alpha regulatory pathway. Cell Metab. 4: 199-210.
29. Choi, C. S., D. B. Savage, A. Kulkarni, X. X. Yu, Z. X. Liu, K. Morino, S. Kim, A. Distefano, V. T. Samuel, S. Neschen, et al. 2007. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J. Biol. Chem. 282: 22678-22688.
30. Yu, X. X., S. F. Murray, S. K. Pandey, S. L. Booten, D. J. Bao, X. Z. Song, S. Kelly, S. Y. Chen, R. Mckay, B. P. Monia, et al. 2005. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology. 42: 362-371.
31. Monetti, M., M. C. Levin, M. J. Watt, M. P. Sajan, S. Marmor, B. K. Hubbard, R. D. Stevens, J. R. Bain, C. B. Newgard, R. V. Farese, et al. 2007. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6: 69-78.
32. Lobo, S., B. M. Wiczer, A. J. Smith, A. M. Hall, and D. A. Bernlohr. 2007. Fatty acid metabolism in adipocytes: functional analysis of fatty acid transport proteins 1 and 4. J. Lipid Res. 48: 609-620.
33. Kanaley, J. A., S. Shadid, M. T. Sheehan, Z. Guo, and M. D. Jensen. 2009. Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans. J. Physiol. 587: 5939-5950.
34. Adamo, K. B., R. Dent, C. D. Langefeld, M. Cox, K. Williams, K. M. Carrick, J. S. Stuart, S. S. Sundseth, M. E. Harper, R. McPherson, et al. 2007. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring). 15: 1068-1075.
35. Durgan, D. J., J. K. Smith, M. A. Hotze, O. Egbejimi, K. D. Cuthbert, V. G. Zaha, J. R. B. Dyck, E. D. Abel, and M. E. Young. 2006. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. Am. J. Physiol. Heart Circ. Physiol. 290: H2480-H2497.
36. Marszalek, J. R., C. Kitidis, A. Dararutana, and H. F. Lodish. 2004. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J. Biol. Chem. 279: 23882-23891.
37. Chiu, H. C., A. Kovacs, D. A. Ford, F. F. Hsu, R. Garcia, P. Herrero, J. E. Saffitz, and J. E. Schaffer. 2001. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107: 813-822.
38. Frederiksen, K. S., E. M. Wulff, P. Sauerberg, J. P. Mogensen, L. Jeppesen, and J. Fleckner. 2004. Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles. J. Lipid Res. 45: 592-601.
39. Li, L. O., J. M. Ellis, H. A. Paich, S. L. Wang, N. Gong, G. Altshuller, R. J. Thresher, T. R. Koves, S. M. Watkins, D. M. Muoio, et al. 2009. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition. J. Biol. Chem. 284: 27816-27826.
40. Diraison, F., E. Dusserre, H. Vidal, M. Sothier, and M. Beylot. 2002. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am. J. Physiol. Endocrinol. Metab. 282: E46-E51.
41. Vedala, A., W. Wang, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein. 2006. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J. Lipid Res. 47: 2562-2574.
42. Hoy, A. J., A. E. Brandon, N. Turner, M. J. Watt, C. R. Bruce, G. J. Cooney, and E. W. Kraegen. 2009. Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. Am. J. Physiol. Endocrinol. Metab. 297: E67-E75.